Clinical Trial Update: Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

View source ↗

Summary

A real-world prospective study evaluating the use of anti-CGRP migraine therapies, currently recruiting at a Spanish research institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AIMOVIG (ERENUMAB-AOOE)
• Ajovy (fremanezumab)
• Emgality (galcanezumab)
• VYEPTI (eptinezumab)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Migraine, Episodic Migraine | Status: RECRUITING